X. Chen et al., Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4 + CD25 + T regulatory cells. J. Immunol 179(1), 154–161 (2007)

Article  PubMed  Google Scholar 

X. Chen et al., TNFR2 is critical for the stabilization of the CD4 + Foxp3 + regulatory T cell phenotype in the inflammatory environment. J. Immunol 190(3), 1076–1084 (2013)

Article  PubMed  Google Scholar 

X. Chen et al., Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer. PLoS ONE 9(1), e85398 (2014)

Article  PubMed  PubMed Central  Google Scholar 

X. Chen et al., Cutting edge: Expression of TNFR2 defines a maximally suppressive subset of mouse CD4 + CD25 + Foxp3 + T regulatory cells: Applicability to tumor-infiltrating T regulatory cells. J. Immunol 180(10), 6467 (2008)

Article  PubMed  Google Scholar 

C. Govindaraj et al., Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2 + Tregs within the tumor microenvironment. Clin. Immunol 149(1), 97–110 (2013)

Article  PubMed  Google Scholar 

M. Wang et al., Increased regulatory T cells in peripheral blood of acute myeloid leukemia patients rely on tumor necrosis factor (TNF)-α-TNF receptor-2 pathway. Front. Immunol 9, 1274–1274 (2018)

Article  PubMed  PubMed Central  Google Scholar 

F. Yan et al., Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients. Cancer Immunol. Immunother 64(11), 1475–1485 (2015)

Article  PubMed  Google Scholar 

N.C. Kampan et al., Interleukin 6 present in inflammatory ascites from advanced epithelial ovarian cancer patients promotes tumor necrosis factor receptor 2-expressing regulatory T cells. Front. Immunol. 8(1482) (2017)

L.-L. Ye et al., Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Ann. Transl. Med. 8(24), 1647 (2020)

Article  PubMed  PubMed Central  Google Scholar 

X. Chen, J.J. Oppenheim, Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer. Sci. Signal 10(462), eaal2328 (2017)

Article  PubMed  Google Scholar 

ÉS. Vanamee, D.L. Faustman, TNFR2: A novel target for cancer immunotherapy. Trends Mol. Med 23(11), 1037–1046 (2017)

Article  PubMed  Google Scholar 

H. Zou et al., Modulation of regulatory T cell activity by TNF receptor type II-targeting pharmacological agents. Front. Immunol. 9 (2018)

Y. Nie et al., Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Sci. Signal 11(511), eaan0790 (2018)

Article  PubMed  PubMed Central  Google Scholar 

K. Case et al., TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models. J. Leukoc. Biol 107(6), 981–991 (2020)

Article  PubMed  Google Scholar 

M. Jiang et al., A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer. Int. Immunopharmacol. 101(Pt A), 108345 (2021)

H. Torrey et al., Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome. Leukemia (2018)

H. Torrey et al., Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs. Sci. Signal 10(462), eaaf8608 (2017)

Article  PubMed  Google Scholar 

X. Chen et al., Differential response of murine CD4 + CD25 + and CD4 + CD25– T cells to dexamethasone-induced cell death. Eur. J. Immunol 34(3), 859–869 (2004)

Article  PubMed  Google Scholar 

K.N. Atretkhany et al., Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 115(51), 13051–13056 (2018)

Article  PubMed  PubMed Central  Google Scholar 

H. Torrey et al., Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome. Leukemia 33(5), 1206–1218 (2019)

Article  PubMed  Google Scholar 

X. Chen et al., Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3 + CD4 + CD25 + T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol 36(8), 2139–2149 (2006)

Article  PubMed  Google Scholar 

C.C. Preston et al., The ratios of CD8 + T cells to CD4 + CD25 + FOXP3 + and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. PLoS ONE 8(11), e80063 (2013)

Article  PubMed  PubMed Central  Google Scholar 

A.S. Baras et al., The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder. Oncoimmunology 5(5), e1134412 (2016)

Article  PubMed  PubMed Central  Google Scholar 

B. Zaragoza et al., Suppressive activity of human regulatory T cells is maintained in the presence of TNF. Nat. Med 22(1), 16–17 (2016)

Article  PubMed  PubMed Central  Google Scholar 

E. Ronin et al., Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells. Proc. Natl. Acad. Sci. U. S. A. 118(13) (2021)

S. Dias et al., Effector regulatory T cell differentiation and immune homeostasis depend on the transcription factor Myb. Immunity 46(1), 78–91 (2017)

Article  PubMed  Google Scholar 

M. di LubranoRicco et al., Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κB. Eur. J. Immunol 50(7), 972–985 (2020)

Article  Google Scholar 

D. Mougiakakos et al., Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 117(3), 857–861 (2011)

Article  PubMed  Google Scholar 

F. Chalmin et al., Regulation of T cell antitumor immune response by tumor induced metabolic stress. Cell. stress 3(1), 9–18 (2018)

Article  PubMed  PubMed Central  Google Scholar 

M.J. Watson et al., Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591(7851), 645–651 (2021)

Article  PubMed  PubMed Central  Google Scholar 

I. Pacella et al., Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth Proceedings of the National Academy of Sciences, 2018. 115(28): p. E6546-E6555

S.A. Lim et al., Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature 591(7849), 306–311 (2021)

Article  PubMed  PubMed Central  Google Scholar 

J.K. Sethi, G.S. Hotamisligil, Metabolic messengers: tumour necrosis factor. Nat. Metab. 3(10), 1302–1312 (2021)

Article  PubMed  Google Scholar 

M. Mensink et al., TNFR2 costimulation differentially impacts regulatory and conventional CD4 + T-cell metabolism. Front. Immunol. 13 (2022)

S. de Kivit et al., Stable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation. Nat. Metab. 2(10), 1046–1061 (2020)

Article  PubMed  Google Scholar 

M. Chopra et al., Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J. Exp. Med 213(9), 1881–1900 (2016)

Article  PubMed  PubMed Central  Google Scholar 

E.M. Tam et al., Antibody-mediated targeting of TNFR2 activates CD8(+) T cells in mice and promotes antitumor immunity. Sci. Transl. Med. 11(512) (2019)

X. Chen et al., TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis. Sci. Rep 6, 32834 (2016)

Article  PubMed  PubMed Central  Google Scholar 

M.S. Alam et al., TNF plays a crucial role in inflammation by signaling via T cell TNFR2. Proc. Natl. Acad. Sci. 118(50), e2109972118 (2021)